Stay updated with breaking news from Appia Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Appia Bio, Inc., a biotechnology company developing allogeneic chimeric antigen receptor (CAR)-engineered invariant natural killer T (CAR-NKT)...
Appia Bio is a biotech company with the mission of discovering and developing next-generation allogeneic cell therapies for cancer patients.
Los Angeles-based biotechnology company Appia Bio said this morning that it has named Robert S. Negrin, M.D., to its Scientific Advisory Board. Dr. Negrin is a professor of medicine and former chief of th
/PRNewswire/ -- Appia Bio, Inc., a preclinical-stage biotechnology company developing allogeneic chimeric antigen receptor natural killer T (CAR-NKT) cell...
/PRNewswire/ -- The Southern California Biomedical Council (SoCalBio) -- the trade association for bioscience and digital health professionals across Greater...